SAGITTARIUS consortium and clinical network

SAGITTARIUS is a large and multifaceted clinical trial project. It is being led by a highly multidisciplinary consortium of data scientists, health and social care experts from 5 different European countries - Italy, Belgium, Estonia, Spain, and Germany. The Consortium works alongside a network of highly qualified cancer centres in Italy, Spain and Germany where the SAGITTARIUS approach will be clinically tested.

SAGITTARIUS Consortium and Clinical Network

The Consortium

The consortium behind the SAGITTARIUS project consists of 8 partners carefully selected on the basis of their specific competences and potential contribution to the project objectives.

Partners

IFOM

IFOM - Istituto Fondazione di Oncologia Molecolare Ets, Italy
Design and management and logistics of SAGITTARIUS clinical trial. Overall project management.
➼ Website

Cogentech
COGENTECH srl - Consortium for Genomic Technologies Societa Benefit Srl, Italy
IFOM affiliated partner.
Tumor genetic profiling.
➼ Website
AIRC

AIRC ETS - Fondazione Airc per la ricerca sul cancro Ets, Italy
Stakeholder engagement, communication, and dissemination of materials.
➼ Website

IMIM

Hospital del Mar Research Institute Barcelona, Spain
Clinical trial execution.
➼ Website

Bocconi
Università Commerciale Luigi Bocconi, Italy
Cost-effectiveness analysis.
➼ Website
DiCE
DiCE – Digestive Cancers Europe, Belgium
Stakeholder engagement, communication, and dissemination of materials.
➼ Website
SporeData

Sporadata OU, Estonia
Integrated data analysis.
➼ Website

VHIO
VHIO – Vall d’Hebron Instituto de Oncología, Spain
Clinical trial execution.
➼ Website
Charité
Charité – Universitätsmedizin Berlin, Germany
Clinical trial execution.
➼ Website

The clinical network

The SAGITTARIUS approach to the post-surgical care of patients with operable locoregional colon cancer will be experimentally tested across the EU in three different countries - Italy, Spain and Germany - involving a network of 26 EU clinical centres.

For Italy:

  • Grande Ospedale Metropolitano Niguarda (Milan), Salvatore Siena and Andrea Sartore-Bianchi
  • Istituto Clinico Humanitas (Rozzano), Armando Santoro
  • Istituto Europeo di Oncologia (Milan), Maria Giulia Zampino
  • Fondazione Poliambulanza (Brescia), Michela Libertini
  • Azienda Unità Sanitaria Locale della Romagna (Ravenna), Stefano Tamberi
  • Ospedale Maggiore di Novara (Novara), Alessandra Gennari
  • Istituto di Candiolo (Candiolo), Patrizia Racca
  • Policlinico Universitario Gemelli (Rome), Lisa Salvatore
  • Azienda Ospedaliera Universitaria San Martino (Genoa), Maria Stefania Sciallero
  • Azienda Ospedaliera Universitaria di Parma (Parma), Francesca Negri
  • Ospedale Santa Maria della Misericordia (Perugia), Mario Mandalà
  • Azienda Sanitaria Locale di Biella (Biella), Francesco Leone

For Spain:

  • Hospital del Mar (Barcelona), Clara Montagut
  • Hospital Vall d’Hebrón (Barcelona), Elena Élez
  • Hospital Sant Pau Barcelona (Barcelona), David Páez
  • Instituto Catalán de Oncologia (Barcelona), Cristina Santos
  • Hospital 12 de Octubre (Madrid), Cristina Graválos
  • Hospital Clinico Universitario San Carlos (Madrid), Javier Sastre
  • INCLIVA Instituto de Investigación Sanitaria (València), Noelia Tarazona
  • Hospital General Universitario de València (València), Maria José Safont
  • Hospital Universitario Marqués de Valdecilla (Santander, Cantabria), Carlos López
  • Hospital Universitario Reina Sofía (Córdoba), Enrique Aranda
  • Hospital Clínico Universitario de Santiago (Santiago de Compostela), Juan Ruiz
  • Hospital Universitario Miguel Servet (Zaragoza), Vicente Alonso
  • Complejo Hospitalario de Navarra (Navarra), Ruth Vera

For Germany:

  • Charité - Universitätsmedizin Berlin (Berlin), Sebastian Stintzing and Loredana Vecchione.

In order to facilitate the use of our website, we use cookies.

Please confirm if you accept cookies. When declining the cookies, you can continue visiting the website without sending data to third party services. Read our complete cookie statement here.